Does Prolonged Naltrexone Therapy Alter the Rewarding Nature of Exercise, Socialization, and Eating? A Narrative Review
Introduction: Naltrexone is an opioid receptor antagonist prescribed for alcohol use disorder and opioid use disorder. Naltrexone has a high affinity for the mu-opioid receptors, which are the primary binding site of beta-endorphin. Beta-endorphin is an endogenous opioid that functions as the medi...
Saved in:
Main Authors: | Caitlin Collier, Thomas Hilton |
---|---|
Format: | Article |
Language: | English |
Published: |
McGill University
2025-01-01
|
Series: | McGill Journal of Medicine |
Subjects: | |
Online Access: | https://mjm.mcgill.ca/article/view/1058 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the antagonist effect of naltrexone implant via opioid challenge tests with escalating doses of hydromorphone injection in former heroin dependent patients
by: Wei Qu, et al.
Published: (2025-01-01) -
Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder
by: Nicholas C. Cardamone, et al.
Published: (2025-02-01) -
Association between different modalities of opioid use disorder-related care delivery and opioid use disorder-related patient outcomes: A retrospective cohort study
by: Nahiyan Bin Noor, et al.
Published: (2025-06-01) -
Assessing medical students’ beliefs about the opioid crisis and their post-graduation plans: a cross-sectional study
by: Samuel Borgemenke, et al.
Published: (2025-02-01) -
Impact of ethnicity on the relevance of the Alcohol Use Disorders Identification Test (AUDIT) in Nepal
by: Susmita Pandey